389 Views | 553 Downloads
Correspondence: Sidney H. Kennedy, sidney.kennedy@uhn.ca
All authors have materially participated in the research and/or article preparation.
SM completed the statistical analysis of the data and wrote the manuscript.
HEM conducted the neuropsychological testing, advised on the analysis of the data and assisted with the preparation of the article for publication.
JG assisted with the statistical analysis and preparation of the article.
PG was involved in the study design and the assessment of the patients recruited for the study, and advised on the preparation of the article.
SR was the coordinator for the original study and she assisted with the preparation of the article.
AC provided input into the acquisition of the data and assistance with the formatting of the article.
AKC contributed to preparation and revision of the article for publication.
HSM contributed to the conception and design of the study.
AL contributed to the conception and design and conducted the neurosurgical procedures.
SK contributed to the conception and design of the study, advised on the interpretation of the data, assisted significantly to the drafting of the article and revised it critically for important intellectual content.
All co-authors gave final approval of the final article.
PG has been a consultant for St. Jude Medical. HSM has received consulting and intellectual licensing fees from St. Jude Medical, Inc. AL has been a Consultant for Medtronic, St. Jude Medical and Boston Scientific.
He has intellectual property in the field of DBS.
SK has received grant/research support from Ontario Brain Institute (OBI) and CIHR.
He has received research support from Lundbeck, St. Jude Medical, Bristol-Myers Squibb, and Clera, Inc.
He has received speaking fees from and/or is a member of an advisory board for: Lundbeck, Lundbeck Institute, Pfizer, Bristol-Myers Squibb, Servier, and Forest, Janssen Pharmaceutical Companies of Johnson and Johnson.
SMI received a CANMAT-Pfizer fellowship during the time this analysis was completed.
SM, PG, AKC, SR, and SK have contributed to the CAN-BIND (Canadian Biomarker Integration Network in Depression) Program which is supported by the OBI.
AC, HEM, and JG have no conflicts of interest.
The study sponsor was University Health Network, Toronto.
This study was supported by a distinguished Investigator Award to Dr. Mayberg from the National Alliance for Research on Schizophrenia and Depression (NARSAD).
This paper was supported by ational Alliance for Research on Schizophrenia and Depression10.13039/100009670.
© 2017 McInerney, McNeely, Geraci, Giacobbe, Rizvi, Ceniti, Cyriac, Mayberg, Lozano and Kennedy.